Skip to content

VETPHARM

Active
Private limited companyfounded 201115 yrs activeKokelarestraat 83, 8870 Izegem, BelgiumKBO/BCE: BE 0839.331.991
Summary

VETPHARM has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €937,060 and a net result of €31,770. Equity remains stable across the filed fiscal years (±0.3% per year). Its solvency ranks better than 23% of 9624 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460
1 site
Size
€5.6mtotal assets 2025
Equity
€937,060
Profit
€31,770
Turnover not published (abridged schema)
Financial health
83 Excellent Checked score 2025
Bankruptcy chance 12 m
0.3%
Structure
Parent
De Sasmeester CommV
Holdings
1
Accounts 51 d early0 of 4 deeds read
Why 83- 1 change of registered office in 24 months- Liquidity: current ratio 1.24, cash €67,101+ Size: total assets €5.6m+ Figures for FY 2025 (filed 10-06-2026)Show the evidence

Checked score

Score 2025
83 / 100
Excellent
Probability in this band: under 0.55%
Better than 23% of its sector peers (NACE 46, small)
Performance against the sector, not lower risk
Financial strength · tick = 2024
Weak
Solvency 42+4
equity 16.8% of total assets
Liquidity 8+6
short-term debt 80.0% · cash 1.2%
Profitability 33-29
return on assets 0.6%
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%

About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.2% (4,378 companies)
Last 24 months 11-2024: 0.3% 12-2024: 0.3%● 0.0% vs 11-2024 01-2025: 0.3%● 0.0% vs 12-2024 02-2025: 0.3%▲ +2.1% vs 01-2025 03-2025: 0.3%▲ +4.8% vs 02-2025 04-2025: 0.3%▲ +10.1% vs 03-2025 05-2025: 0.4%▲ +8.0% vs 04-2025 06-2025: 0.5%▲ +33.7% vs 05-2025 07-2025: 0.3%▼ -39.3% vs 06-2025 08-2025: 0.3%● 0.0% vs 07-2025 09-2025: 0.3%▲ +2.7% vs 08-2025 10-2025: 0.3%● 0.0% vs 09-2025 11-2025: 0.7%▲ +128% vs 10-2025 12-2025: 0.7%● 0.0% vs 11-2025 01-2026: 0.7%● 0.0% vs 12-2025 02-2026: 0.7%▲ +1.9% vs 01-2026 03-2026: 0.7%▲ +1.6% vs 02-2026 04-2026: 0.8%▲ +8.5% vs 03-2026 05-2026: 1.0%▲ +24.8% vs 04-2026 06-2026: 1.1%▲ +8.2% vs 05-2026highest value 07-2026: 0.3%▼ -74.8% vs 06-2026lowest value 08-2026: 0.3%● 0.0% vs 07-2026lowest value 09-2026: 0.3%● 0.0% vs 08-2026lowest value 10-2026: 0.3%● 0.0% vs 09-2026lowest value
  • Size: total assets €5.6m lowers the probability for this profile
  • 1 change of registered office in 24 months raises the probability
  • Liquidity: current ratio 1.24, cash €67,101 raises the probability
  • Figures for FY 2025 (filed 10-06-2026) lowers the probability
Credit up to €75,000 at 30 days acceptable
Liquidity tight (current ratio 1.24 against 1.15 in 2024; short-term debt: 80% and cash: 1.2% of total assets), and 83.2% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 46, small). Better than this share of them on solvency 19%, liquidity 7%, profitability 19%, growth against the median 49%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 04-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Size: total assets €5.6m
In the bankruptcy model this factor lowers the probability for this profile.
NBB · annual accounts
raises risk · 1 change of registered office in 24 months
In the bankruptcy model this factor raises the probability.
Belgian State Gazette
raises risk · Liquidity: current ratio 1.24, cash €67,101
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
lowers risk · Figures for FY 2025 (filed 10-06-2026)
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 23% of 9624 sector peers (2025).
NBB · sector comparison
Position among 9624 sector peers
Solvency
better than 23%
← weakest strongest →
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €937,060
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 10-06-2026, 51 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
51 d early
2024
44 d early
2023
37 d early
2022
39 d early
2021
41 d early
2020
33 d early
2019
37 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 40 days before the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 20 June (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
05-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · abbreviated…
  2. Weakest financial yearnet €31,770 ▼91.6%
  3. Annual accounts filedfiscal year 2024 · abbreviated…

Key points

  • Caution: Result fell in 2025from €376,696 to €31,770 ▼ 91.6% View
  • Positive: Always filed on timeaccounts within the deadline every year 8 years View
  • Positive: 8 profitable years in a rowprofit 2025: €31,770 8 years View
  • Among the largest 7% on total assetssector median €1.0m · 9,611 companies €5.6m View
  • Controlled by De Sasmeester CommV parent View

By topic

Financials

Fiscal year
2025
Total assets
€5.6m
Profit
€31,770
Solvency
16.8%
Total assets▼ 20.4%
Net result
20182025
Go to Financials

Timeline

Events
11
Since
2017
Next accounts
by 31-07-2027
  1. 10-06-2026Annual accounts filed
  2. 31-12-2025Weakest financial year
  3. 17-06-2025Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
26-08-2011
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.